Heat shock fusion protein gp96-Ig mediates strong CD8 CTL expansion in vivo

Natasa Strbo, Koichi Yamazaki, Kelvin Lee, Daniel Rukavina, Eckhard R. Podack

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Problem: As shown previously, gp96-Ig peptide complexes secreted by an ovalbumin transfected tumor (EG7) mediate strong, specific tumor immunity through a CD4 T cell independent CD8+ CTL response. In this study, we set out to develop a system to quantitatively determine the CD8 CTL response to gp96-Ig and to evaluate the influence of an established wild type tumor. Methods: Secreted heat shock protein gp96-Ig was constructed by replacement of the endoplasmic reticulum retention signal with the Fc portion of IgG1, transfected into EG7 (EG7-gp96-Ig) and used to induce CD8+ CTL expansion in vivo. Adoptively transferred, ovalbumin specific T-cell receptor (TCR) transgenic CD8+ cells (OT-1) responded with clonal expansion to the immunization with EG7-gp96-Ig. OT-1 expansion was quantitated with Kb-peptide-tetramers by flow cytometry. Results: In response to primary immunization with EG7-gp96-Ig, OT-1 expand from an initial frequency of 0.5 to 25% of all CD8 cells, and to 50% of all CD8 cells after a booster immunization. Endogenous ovalbumin specific CD8 cells also expand strongly. Antigen specific effector function was measured by enzyme-linked immunosorbent spot-forming cell assay (ELISPOT) for interferon-γ (IFN-γ). While effector function was strongly induced by secreted gp96-Ig, not all expanded OT-1 produce IFN-γ. EG7 does not cause OT-1 expansion, but rather induces anergy. If OT-1 are transferred into wild type EG7 tumor bearing mice to induce anergy of OT-1, immunization with EG7-gp96-Ig can partly overcome unresponsiveness. Conclusions: We conclude that secreted gp96-Ig is a powerful mediator of specific CD8+ CTL responses in vivo. Secretory gp96 mimics release of gp96 by damaged or necrotic cells that is able to activate dendritic cells without CD4 help. Gp96-Ig associated peptides have not been selected by binding to major histocompatibility complex (MHC). Specific immunization by secreted gp96-Ig therefore is expected to occur also in allogeneic settings.

Original languageEnglish
Pages (from-to)220-225
Number of pages6
JournalAmerican Journal of Reproductive Immunology
Volume48
Issue number4
DOIs
StatePublished - Oct 1 2002

Fingerprint

Heat-Shock Proteins
Immunization
Ovalbumin
Interferons
Peptides
Neoplasms
Secondary Immunization
Immunosorbents
T-Cell Antigen Receptor
Major Histocompatibility Complex
Endoplasmic Reticulum
Dendritic Cells
Immunity
Flow Cytometry
Immunoglobulin G
T-Lymphocytes
Antigens
Enzymes

Keywords

  • Cytotoxicity
  • Dendritic cells
  • MHC tetramer
  • Vaccine

ASJC Scopus subject areas

  • Immunology
  • Obstetrics and Gynecology

Cite this

Heat shock fusion protein gp96-Ig mediates strong CD8 CTL expansion in vivo. / Strbo, Natasa; Yamazaki, Koichi; Lee, Kelvin; Rukavina, Daniel; Podack, Eckhard R.

In: American Journal of Reproductive Immunology, Vol. 48, No. 4, 01.10.2002, p. 220-225.

Research output: Contribution to journalArticle

Strbo, Natasa ; Yamazaki, Koichi ; Lee, Kelvin ; Rukavina, Daniel ; Podack, Eckhard R. / Heat shock fusion protein gp96-Ig mediates strong CD8 CTL expansion in vivo. In: American Journal of Reproductive Immunology. 2002 ; Vol. 48, No. 4. pp. 220-225.
@article{082617cdb2a54b7e9a9fdf4a37567165,
title = "Heat shock fusion protein gp96-Ig mediates strong CD8 CTL expansion in vivo",
abstract = "Problem: As shown previously, gp96-Ig peptide complexes secreted by an ovalbumin transfected tumor (EG7) mediate strong, specific tumor immunity through a CD4 T cell independent CD8+ CTL response. In this study, we set out to develop a system to quantitatively determine the CD8 CTL response to gp96-Ig and to evaluate the influence of an established wild type tumor. Methods: Secreted heat shock protein gp96-Ig was constructed by replacement of the endoplasmic reticulum retention signal with the Fc portion of IgG1, transfected into EG7 (EG7-gp96-Ig) and used to induce CD8+ CTL expansion in vivo. Adoptively transferred, ovalbumin specific T-cell receptor (TCR) transgenic CD8+ cells (OT-1) responded with clonal expansion to the immunization with EG7-gp96-Ig. OT-1 expansion was quantitated with Kb-peptide-tetramers by flow cytometry. Results: In response to primary immunization with EG7-gp96-Ig, OT-1 expand from an initial frequency of 0.5 to 25{\%} of all CD8 cells, and to 50{\%} of all CD8 cells after a booster immunization. Endogenous ovalbumin specific CD8 cells also expand strongly. Antigen specific effector function was measured by enzyme-linked immunosorbent spot-forming cell assay (ELISPOT) for interferon-γ (IFN-γ). While effector function was strongly induced by secreted gp96-Ig, not all expanded OT-1 produce IFN-γ. EG7 does not cause OT-1 expansion, but rather induces anergy. If OT-1 are transferred into wild type EG7 tumor bearing mice to induce anergy of OT-1, immunization with EG7-gp96-Ig can partly overcome unresponsiveness. Conclusions: We conclude that secreted gp96-Ig is a powerful mediator of specific CD8+ CTL responses in vivo. Secretory gp96 mimics release of gp96 by damaged or necrotic cells that is able to activate dendritic cells without CD4 help. Gp96-Ig associated peptides have not been selected by binding to major histocompatibility complex (MHC). Specific immunization by secreted gp96-Ig therefore is expected to occur also in allogeneic settings.",
keywords = "Cytotoxicity, Dendritic cells, MHC tetramer, Vaccine",
author = "Natasa Strbo and Koichi Yamazaki and Kelvin Lee and Daniel Rukavina and Podack, {Eckhard R.}",
year = "2002",
month = "10",
day = "1",
doi = "10.1034/j.1600-0897.2002.01118.x",
language = "English",
volume = "48",
pages = "220--225",
journal = "American Journal of Reproductive Immunology and Microbiology",
issn = "1046-7408",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Heat shock fusion protein gp96-Ig mediates strong CD8 CTL expansion in vivo

AU - Strbo, Natasa

AU - Yamazaki, Koichi

AU - Lee, Kelvin

AU - Rukavina, Daniel

AU - Podack, Eckhard R.

PY - 2002/10/1

Y1 - 2002/10/1

N2 - Problem: As shown previously, gp96-Ig peptide complexes secreted by an ovalbumin transfected tumor (EG7) mediate strong, specific tumor immunity through a CD4 T cell independent CD8+ CTL response. In this study, we set out to develop a system to quantitatively determine the CD8 CTL response to gp96-Ig and to evaluate the influence of an established wild type tumor. Methods: Secreted heat shock protein gp96-Ig was constructed by replacement of the endoplasmic reticulum retention signal with the Fc portion of IgG1, transfected into EG7 (EG7-gp96-Ig) and used to induce CD8+ CTL expansion in vivo. Adoptively transferred, ovalbumin specific T-cell receptor (TCR) transgenic CD8+ cells (OT-1) responded with clonal expansion to the immunization with EG7-gp96-Ig. OT-1 expansion was quantitated with Kb-peptide-tetramers by flow cytometry. Results: In response to primary immunization with EG7-gp96-Ig, OT-1 expand from an initial frequency of 0.5 to 25% of all CD8 cells, and to 50% of all CD8 cells after a booster immunization. Endogenous ovalbumin specific CD8 cells also expand strongly. Antigen specific effector function was measured by enzyme-linked immunosorbent spot-forming cell assay (ELISPOT) for interferon-γ (IFN-γ). While effector function was strongly induced by secreted gp96-Ig, not all expanded OT-1 produce IFN-γ. EG7 does not cause OT-1 expansion, but rather induces anergy. If OT-1 are transferred into wild type EG7 tumor bearing mice to induce anergy of OT-1, immunization with EG7-gp96-Ig can partly overcome unresponsiveness. Conclusions: We conclude that secreted gp96-Ig is a powerful mediator of specific CD8+ CTL responses in vivo. Secretory gp96 mimics release of gp96 by damaged or necrotic cells that is able to activate dendritic cells without CD4 help. Gp96-Ig associated peptides have not been selected by binding to major histocompatibility complex (MHC). Specific immunization by secreted gp96-Ig therefore is expected to occur also in allogeneic settings.

AB - Problem: As shown previously, gp96-Ig peptide complexes secreted by an ovalbumin transfected tumor (EG7) mediate strong, specific tumor immunity through a CD4 T cell independent CD8+ CTL response. In this study, we set out to develop a system to quantitatively determine the CD8 CTL response to gp96-Ig and to evaluate the influence of an established wild type tumor. Methods: Secreted heat shock protein gp96-Ig was constructed by replacement of the endoplasmic reticulum retention signal with the Fc portion of IgG1, transfected into EG7 (EG7-gp96-Ig) and used to induce CD8+ CTL expansion in vivo. Adoptively transferred, ovalbumin specific T-cell receptor (TCR) transgenic CD8+ cells (OT-1) responded with clonal expansion to the immunization with EG7-gp96-Ig. OT-1 expansion was quantitated with Kb-peptide-tetramers by flow cytometry. Results: In response to primary immunization with EG7-gp96-Ig, OT-1 expand from an initial frequency of 0.5 to 25% of all CD8 cells, and to 50% of all CD8 cells after a booster immunization. Endogenous ovalbumin specific CD8 cells also expand strongly. Antigen specific effector function was measured by enzyme-linked immunosorbent spot-forming cell assay (ELISPOT) for interferon-γ (IFN-γ). While effector function was strongly induced by secreted gp96-Ig, not all expanded OT-1 produce IFN-γ. EG7 does not cause OT-1 expansion, but rather induces anergy. If OT-1 are transferred into wild type EG7 tumor bearing mice to induce anergy of OT-1, immunization with EG7-gp96-Ig can partly overcome unresponsiveness. Conclusions: We conclude that secreted gp96-Ig is a powerful mediator of specific CD8+ CTL responses in vivo. Secretory gp96 mimics release of gp96 by damaged or necrotic cells that is able to activate dendritic cells without CD4 help. Gp96-Ig associated peptides have not been selected by binding to major histocompatibility complex (MHC). Specific immunization by secreted gp96-Ig therefore is expected to occur also in allogeneic settings.

KW - Cytotoxicity

KW - Dendritic cells

KW - MHC tetramer

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=0036785091&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036785091&partnerID=8YFLogxK

U2 - 10.1034/j.1600-0897.2002.01118.x

DO - 10.1034/j.1600-0897.2002.01118.x

M3 - Article

C2 - 12516632

AN - SCOPUS:0036785091

VL - 48

SP - 220

EP - 225

JO - American Journal of Reproductive Immunology and Microbiology

JF - American Journal of Reproductive Immunology and Microbiology

SN - 1046-7408

IS - 4

ER -